DXCM

Dexcom Inc
$84.74-$0.02-0.02%Price as of Nov 3, 2026, 9:30 AM ET

Key stats

Market cap
31.6B
Open
—
Day range
—
52-week range
$54.11 – $92.59
Volume
39.2K
Avg volume
4.73M

Earnings

Q3 FY26Beat
Expected$0.69
Actual$0.73
Q2 FY26
Actual$0.64
Q1 FY26
Actual$0.51
Q4 FY25
Actual$0.67

Next earnings call Feb 11, 2027

About

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Employees
11,100
Headquarters
San Diego, CA